BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 28941561)

  • 1. The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015.
    Karimkhani C; Colombara DV; Drucker AM; Norton SA; Hay R; Engelman D; Steer A; Whitfeld M; Naghavi M; Dellavalle RP
    Lancet Infect Dis; 2017 Dec; 17(12):1247-1254. PubMed ID: 28941561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Risk Factor Collaborators
    Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD Chronic Respiratory Disease Collaborators
    Lancet Respir Med; 2020 Jun; 8(6):585-596. PubMed ID: 32526187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Mental Disorders Collaborators
    Lancet Psychiatry; 2022 Feb; 9(2):137-150. PubMed ID: 35026139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Diabetes Collaborators
    Lancet; 2023 Jul; 402(10397):203-234. PubMed ID: 37356446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
    Murray CJ; Vos T; Lozano R; Naghavi M; Flaxman AD; Michaud C; Ezzati M; Shibuya K; Salomon JA; Abdalla S; Aboyans V; Abraham J; Ackerman I; Aggarwal R; Ahn SY; Ali MK; Alvarado M; Anderson HR; Anderson LM; Andrews KG; Atkinson C; Baddour LM; Bahalim AN; Barker-Collo S; Barrero LH; Bartels DH; Basáñez MG; Baxter A; Bell ML; Benjamin EJ; Bennett D; Bernabé E; Bhalla K; Bhandari B; Bikbov B; Bin Abdulhak A; Birbeck G; Black JA; Blencowe H; Blore JD; Blyth F; Bolliger I; Bonaventure A; Boufous S; Bourne R; Boussinesq M; Braithwaite T; Brayne C; Bridgett L; Brooker S; Brooks P; Brugha TS; Bryan-Hancock C; Bucello C; Buchbinder R; Buckle G; Budke CM; Burch M; Burney P; Burstein R; Calabria B; Campbell B; Canter CE; Carabin H; Carapetis J; Carmona L; Cella C; Charlson F; Chen H; Cheng AT; Chou D; Chugh SS; Coffeng LE; Colan SD; Colquhoun S; Colson KE; Condon J; Connor MD; Cooper LT; Corriere M; Cortinovis M; de Vaccaro KC; Couser W; Cowie BC; Criqui MH; Cross M; Dabhadkar KC; Dahiya M; Dahodwala N; Damsere-Derry J; Danaei G; Davis A; De Leo D; Degenhardt L; Dellavalle R; Delossantos A; Denenberg J; Derrett S; Des Jarlais DC; Dharmaratne SD; Dherani M; Diaz-Torne C; Dolk H; Dorsey ER; Driscoll T; Duber H; Ebel B; Edmond K; Elbaz A; Ali SE; Erskine H; Erwin PJ; Espindola P; Ewoigbokhan SE; Farzadfar F; Feigin V; Felson DT; Ferrari A; Ferri CP; Fèvre EM; Finucane MM; Flaxman S; Flood L; Foreman K; Forouzanfar MH; Fowkes FG; Fransen M; Freeman MK; Gabbe BJ; Gabriel SE; Gakidou E; Ganatra HA; Garcia B; Gaspari F; Gillum RF; Gmel G; Gonzalez-Medina D; Gosselin R; Grainger R; Grant B; Groeger J; Guillemin F; Gunnell D; Gupta R; Haagsma J; Hagan H; Halasa YA; Hall W; Haring D; Haro JM; Harrison JE; Havmoeller R; Hay RJ; Higashi H; Hill C; Hoen B; Hoffman H; Hotez PJ; Hoy D; Huang JJ; Ibeanusi SE; Jacobsen KH; James SL; Jarvis D; Jasrasaria R; Jayaraman S; Johns N; Jonas JB; Karthikeyan G; Kassebaum N; Kawakami N; Keren A; Khoo JP; King CH; Knowlton LM; Kobusingye O; Koranteng A; Krishnamurthi R; Laden F; Lalloo R; Laslett LL; Lathlean T; Leasher JL; Lee YY; Leigh J; Levinson D; Lim SS; Limb E; Lin JK; Lipnick M; Lipshultz SE; Liu W; Loane M; Ohno SL; Lyons R; Mabweijano J; MacIntyre MF; Malekzadeh R; Mallinger L; Manivannan S; Marcenes W; March L; Margolis DJ; Marks GB; Marks R; Matsumori A; Matzopoulos R; Mayosi BM; McAnulty JH; McDermott MM; McGill N; McGrath J; Medina-Mora ME; Meltzer M; Mensah GA; Merriman TR; Meyer AC; Miglioli V; Miller M; Miller TR; Mitchell PB; Mock C; Mocumbi AO; Moffitt TE; Mokdad AA; Monasta L; Montico M; Moradi-Lakeh M; Moran A; Morawska L; Mori R; Murdoch ME; Mwaniki MK; Naidoo K; Nair MN; Naldi L; Narayan KM; Nelson PK; Nelson RG; Nevitt MC; Newton CR; Nolte S; Norman P; Norman R; O'Donnell M; O'Hanlon S; Olives C; Omer SB; Ortblad K; Osborne R; Ozgediz D; Page A; Pahari B; Pandian JD; Rivero AP; Patten SB; Pearce N; Padilla RP; Perez-Ruiz F; Perico N; Pesudovs K; Phillips D; Phillips MR; Pierce K; Pion S; Polanczyk GV; Polinder S; Pope CA; Popova S; Porrini E; Pourmalek F; Prince M; Pullan RL; Ramaiah KD; Ranganathan D; Razavi H; Regan M; Rehm JT; Rein DB; Remuzzi G; Richardson K; Rivara FP; Roberts T; Robinson C; De Leòn FR; Ronfani L; Room R; Rosenfeld LC; Rushton L; Sacco RL; Saha S; Sampson U; Sanchez-Riera L; Sanman E; Schwebel DC; Scott JG; Segui-Gomez M; Shahraz S; Shepard DS; Shin H; Shivakoti R; Singh D; Singh GM; Singh JA; Singleton J; Sleet DA; Sliwa K; Smith E; Smith JL; Stapelberg NJ; Steer A; Steiner T; Stolk WA; Stovner LJ; Sudfeld C; Syed S; Tamburlini G; Tavakkoli M; Taylor HR; Taylor JA; Taylor WJ; Thomas B; Thomson WM; Thurston GD; Tleyjeh IM; Tonelli M; Towbin JA; Truelsen T; Tsilimbaris MK; Ubeda C; Undurraga EA; van der Werf MJ; van Os J; Vavilala MS; Venketasubramanian N; Wang M; Wang W; Watt K; Weatherall DJ; Weinstock MA; Weintraub R; Weisskopf MG; Weissman MM; White RA; Whiteford H; Wiebe N; Wiersma ST; Wilkinson JD; Williams HC; Williams SR; Witt E; Wolfe F; Woolf AD; Wulf S; Yeh PH; Zaidi AK; Zheng ZJ; Zonies D; Lopez AD; AlMazroa MA; Memish ZA
    Lancet; 2012 Dec; 380(9859):2197-223. PubMed ID: 23245608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study.
    India State-Level Disease Burden Initiative Collaborators
    Lancet; 2017 Dec; 390(10111):2437-2460. PubMed ID: 29150201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Neurology Collaborators
    Lancet Neurol; 2019 May; 18(5):459-480. PubMed ID: 30879893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2016 Oct; 388(10053):1545-1602. PubMed ID: 27733282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in disease burden in Poland between 1990-2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017.
    Gańczak M; Miazgowski T; Kożybska M; Kotwas A; Korzeń M; Rudnicki B; Nogal T; Andrei CL; Ausloos M; Banach M; Brazinova A; Constantin MM; Dubljanin E; Herteliu C; Hostiuc M; Hostiuc S; Jakovljevic M; Jozwiak JJ; Kissimova-Skarbek K; Król ZJ; Mestrovic T; Miazgowski B; Milevska Kostova N; Naghavi M; Negoi I; Negoi RI; Pana A; Rubino S; Sekerija M; Sierpinski R; Szponar L; Topor-Madry R; Vujcic IS; Widecka J; Widecka K; Wojtyniak B; Zadnik V; Kopec JA
    PLoS One; 2020; 15(3):e0226766. PubMed ID: 32119685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Brain and Other CNS Cancer Collaborators
    Lancet Neurol; 2019 Apr; 18(4):376-393. PubMed ID: 30797715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global burden of cutaneous leishmaniasis: a cross-sectional analysis from the Global Burden of Disease Study 2013.
    Karimkhani C; Wanga V; Coffeng LE; Naghavi P; Dellavalle RP; Naghavi M
    Lancet Infect Dis; 2016 May; 16(5):584-591. PubMed ID: 26879176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Inflammatory Bowel Disease Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):17-30. PubMed ID: 31648971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of Skin and Subcutaneous Diseases in Iran and Neighboring Countries: Results from the Global Burden of Disease Study 2015.
    Karimkhani C; Dellavalle RP; Karimi SM; Rahimi-Movaghar V; Pourmalek F; Kiadaliri AA; Sahraian MA; Roshandel G; Fereshtehnejad SM; Qorbani M; Radfar A; Farvid MS; Asayesh H; Sepanlou SG; Djalalinia S; Kasaeian A; Khubchandani J; Malekzadeh R; Moradi-Lakeh M; Krohn KJ; Mokdad AH; Vos T; Naghavi M
    Arch Iran Med; 2017 Jul; 20(7):429-440. PubMed ID: 28745904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.
    Murray CJ; Lopez AD
    Lancet; 1997 May; 349(9063):1436-42. PubMed ID: 9164317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
    GBD 2017 Stomach Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):42-54. PubMed ID: 31648970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
    GBD 2015 Tobacco Collaborators
    Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Benign Prostatic Hyperplasia Collaborators
    Lancet Healthy Longev; 2022 Nov; 3(11):e754-e776. PubMed ID: 36273485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.
    Whiteford HA; Degenhardt L; Rehm J; Baxter AJ; Ferrari AJ; Erskine HE; Charlson FJ; Norman RE; Flaxman AD; Johns N; Burstein R; Murray CJ; Vos T
    Lancet; 2013 Nov; 382(9904):1575-86. PubMed ID: 23993280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Gastro-oesophageal Reflux Disease Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):561-581. PubMed ID: 32178772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.